Tyme Technologies, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-12-30: Form 8-K; Period of report 2016-12-29; Description 8.01 Other Events; Details 8.01.
- 2016-11-01: Form 8-K; Period of report 2016-10-27; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 5.03.
- 2016-05-13: Form 8-K; Period of report 2016-05-09; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2016-05-13: Form 8-K; Period of report 2016-05-09; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-12-30 | 8-K | 2016-12-29 | 8.01 Other Events | 8.01 Tyme Technologies, Inc. (OTC QB: TYMI)(the “Company”), a clinical-stage pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications, announced that it raised $1.47 million through a private placement of 452,309 shares of its common stock. | form_8-k.htm |
| 2016-11-01 | 8-K | 2016-10-27 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 (b) On October 27, 2016, the Board of Directors of Tyme Technologies, Inc. (the “Company”) determined to change the fiscal year of the Company from a year ending on December 31 of each year to a year ending on March 31 of each year. | form_8-k.htm |
| 2016-05-13 | 8-K | 2016-05-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (e) On May 9, 2016, the Company’s board of directors (the “Board”) approved certain compensation arrangements and awards as are summarized below. | form_8-k.htm |
| 2016-05-13 | 8-K | 2016-05-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On May 9, 2016, Tommy G. Thompson was elected to serve on the Company’s board of directors (the “Board”). | form_8-k.htm |
| 2016-05-10 | 8-K | 2016-05-10 | 2.02 Results of Operations and Financial Condition | 2.02 On May 10, 2016, the Company issued a press release announcing its financial results for the quarterly period ended March 31, 2016. | form_8-k.htm |
| 2016-05-03 | 8-K | 2016-04-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On April 27, 2016, Patrick LePore resigned from the Company’s board of directors (the “Board”). | form_8-k.htm |
| 2016-02-08 | 8-K | 2016-02-02 | 3.02 Unregistered Sales of Equity Securities | 3.02 Pursuant to a Securities Purchase Agreement, dated as of February 2, 2016 (the “Securities Purchase Agreement”), for the aggregate consideration of $3,100,000, we sold and issued to a total of two individuals an aggregate of: (x) 775,000 shares (each, a “Share”) of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company and (y) 461,384 common stock purchase warrants (each, a “Warrant”). | form_8-k.htm |
| 2016-02-02 | 8-K | 2016-01-27 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form_8-k.htm |